Our Services
Medicare Organ Acquisition Cost Report
Evaluate Opportunity. Minimize Risk. Build for Success.
Accuracy in your Medicare Organ Acquisition Cost Report directly impacts reimbursement and compliance. Guidry & East delivers expert review that identifies reimbursement opportunities, strengthens reporting accuracy, and helps reduce compliance risk.
Organ acquisition costs represent a significant financial component of transplant operations. Our specialized review helps transplant centers identify missed reimbursement opportunities, validate reporting practices, and strengthen the integrity of the Medicare cost report.
— Key Areas of Review —
Optimize Organ Acquisition Reimbursement
Identify Missed
Reimbursement Opportunities
Reduce Audit &
Compliance Risk
Validate Medicare Usable Organ Counts
Ensure Accurate Capture of
Acquisition-Related Expenses
Review HLA & Pre-Transplant
Cost Allocation
Strengthen Internal Reporting & Documentation
Prospective Review
A proactive review performed prior to filing to evaluate reporting accuracy, identify potential compliance concerns, and support appropriate capture and allocation of eligible organ acquisition costs.
- Identify potential audit or compliance concerns
- Evaluate capture of allowable pre-transplant costs
- Validate Medicare usable & total usable organ counts
- Review Medicare Secondary Payer accounts
- Evaluate capture & allocation of HLA costs
- Strengthen documentation & reporting accuracy prior to filing
Retrospective Review
A historical review designed to identify potential reimbursement opportunities, evaluate existing reporting methodologies and controls, and support amended filings when appropriate.
- Identify previously missed reimbursement opportunities
- Support amended filings & recovery of eligible reimbursement
- Evaluate existing policies, procedures, and reporting methodologies
- Review organ acquisition cost classification and allocation
- Identify potential compliance concerns
- Provide recommendations to strengthen future reporting accuracy
Strategic Insight. Financial Impact.
Guidry & East combines transplant-specific expertise with a comprehensive understanding of organ acquisition cost reporting to strengthen reimbursement, reporting accuracy, and compliance.